5 March 2021: The Federal Ministers give a final decision (positive) for this trial
File:
Trial reference:
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy